Canaccord Lowers Targets On Numerous Top Level Cannabis Equities

On February 4th, Canaccord Genuity came out with their cannabis fourth quarter 2021 preview. On that note, they lowered almost every single 12-month price target in their cannabis coverage.

  • Ayr Wellness (CSE: AYR.a) price target was lowered to C$57 from C$62
  • Columbia Care’s (CSE: CCHW) was lowered to C$11 from C$13
  • Cresco Labs (CSE: CL) lowered to C$15 from C$16
  • Curaleaf (CSE: CURA) was dropped from C$22 down to C$18
  • Green Thumb’s (CSE: GTII) lowered to C$46 from C$53
  • Trulieve’s (CSE: TRUL) lowered from C$97 to C$70.

Canaccord says that through their channel checks, they expect a more subdued end to the year with fourth-quarter revenues coming in flatter than at any point in 2021. They believe that this is primarily a function of record-high inflation, making consumers spend more on their other living expenses such as groceries and gas.

Additionally, after speaking to many U.S operators, many have noted that there is a wholesale pricing issue that is expected to continue into 2022 as more capacity continues to come online.

Even with this issue potentially hitting the companies margins, Canaccord expects 2022 to still be a banner year for the sector. They believe that the sector could hit the coveted US$30 billion run rate this year. They add that having exposure to the US cannabis sector currently is a “compelling valuation proposition.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Lastly, Canaccord believes that the >60% drawdown in the USMJ names seen in the last year comes from “structural challenges in the equity markets given that cannabis remains an illicit Schedule 1 drug at the federal level.” Rather than any sort of concerns around the operational side of the businesses.

Below you can see Canaccord’s fourth-quarter earnings previews.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Homeland Nickel Signs Binding Offtake With Westwin for 20,000 Tonnes of Concentrate a Year

Golden Cariboo’s First Quesnelle Resource Estimate Tallies 1.19 Million Gold Equivalent Ounces

Related News

Tesla: Consensus Earnings Expectations For Q2

Tesla (NASDAQ: TSLA) will be reporting their second quarter financial results on July 26th after...

Sunday, July 25, 2021, 11:33:00 AM

Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results

On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company...

Sunday, November 14, 2021, 10:03:00 AM

GFL Environmental: BMO Lifts Target To US$42 After Asset Divesture

At the start of the month, GFL Environmental Inc. (TSX: GFL) announced that they completed...

Friday, October 15, 2021, 11:34:00 AM

Canopy Growth: Cowen & Co Slashes Price Target To $16

On November 5th, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second quarter...

Thursday, November 11, 2021, 04:50:00 PM

Aphria: PI Financial Raises Price Target, Canaccord Reiterates Target

Last week, Aphria Inc (TSX: APHA) (NASDAQ: APHA) reported their year-end and fourth-quarter financial statements....

Sunday, August 2, 2020, 01:30:00 PM